Benjamin Dryden Discusses Impact of Proposed Noncompete Ban on Nonprofit Hospitals
January 20, 2023
Healthcare Dive
Foley & Lardner LLP Partner Benjamin Dryden is quoted in the Healthcare Dive article, “Nonprofit hospitals may evade noncompete ban enforcement, experts say,” discussing the impact on the health care sector – in particular nonprofit hospitals – of the federal government’s proposal to ban noncompete arrangements in employment contracts. The Federal Trade Commission’s proposal would ban future noncompetes while also invalidating existing ones.
Whether the proposed noncompete ban will apply to nonprofit hospitals, which make up half of all the hospitals in the United States, remains unclear.
“The scope of the nonprofit exemption itself is not very well settled,” Dryden, who is vice chair of Foley’s Antitrust Practice Group, commented.
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.